Suppression of ARID1A associated with decreased CD8 T cells improves cell survival of ovarian clear cell carcinoma.

Published in: Journal of gynecologic oncology (2020)

Therapeutic strategies making use of low ARID1A could contribute to better clinical management/research for patients with OCCC.

Keyphrases